COVID-19 Vaccine - en | Covid19.go.id

About COVID-19 Vaccine

Lawan Covid19

What is Vaccination

Vaccination is the administration of vaccines in order to actively generate or increase a person's immunity against a disease, so that if one day they are exposed to the disease, they will not get sick or only experience mild illness and will not become a source of transmission.

COVID-19 vaccination services are carried out at Health Service Facilities owned by the Central Government, Provincial Governments, Regency/City Governments or owned by the public/private sector that meet the requirements, including:

  • Puskesmas, Puskesmas Pembantu
  • Clinic
  • Hospital and/or
  • Health Service Unit at the Port Health Office (KKP)
Or Check Here
District/City Health Offices and Puskesmas can also establish COVID-19 vaccination service posts. It is recommended that each target seek information in advance regarding the service schedule of each health service facility or vaccination service post.

How can Vaccines work in the body to protect us?

  • Vaccines are biological products that are given to a person to protect him or her from a debilitating, even life-threatening disease.
  • Vaccines will stimulate the formation of immunity against certain diseases in a person's body.
  • The body will remember the virus or disease-causing bacteria, recognize and know how to fight it.
Lawan Covid19

List of COVID-19 Vaccines Used in Indonesia

In the implementation of the COVID-19 vaccination program in Indonesia, the government strives for the availability of vaccines to be fulfilled for at least 208,265,720 of the population to achieve group immunity.

These vaccine procurement efforts are carried out through bilateral agreements and multilateral agreements such as the COVAX Facility with GAVI and WHO, or donations provided by friendly countries.

The Indonesian Food and Drug Administration has granted emergency use permits for 10 types of COVID-19 vaccines, namely Sinovac, AstraZeneca, Sinopharm, Moderna, Pfizer, Novavax, Sputnik-V, Janssen, Convidencia, and Zifivax.

Each of these types of vaccines has a mechanism for its own administration, from the number of doses, the interval of administration, to different vaccine platforms, namely inactivated virus, RNA-based, viral-vector, and protein sub-units.

*The vaccines provided are vaccines that have been confirmed to be safe and effective.

SINOVAC VACCINE
COVID-19 Vaccine (Vero Cell) Inactivated, CoronaVac® is an inactivated vaccine against COVID-19 that stimulates the immune system without the risk of causing disease. Once this inactivated vaccine comes into contact with the immune system, antibody production is stimulated, so the body is ready to respond to infection with live SARS-CoV-2. This vaccine contains an adjuvant (aluminum hydroxide), to strengthen the immune system response.
The ChAdOx1-S/nCoV-19 vaccine is a non-replicating adenovirus vector vaccine for COVID-19. The vaccine expresses the SARS-CoV-2 spike protein gene, which instructs the host cell to produce an S-antigen protein unique to SARS-CoV-2, so that the body can generate an immune response and store that information in memory immune cells. Efficacy in clinical trials in participants who received the full course of the vaccine (two doses) in the UK, Brazil, and South Africa regardless of the dose interval was 61%, with a median follow-up period of 80 days, but tends to be higher if this interval is longer. . Additional data from interim analyzes of clinical trials in the United States showed a vaccine efficacy of 76% against symptomatic SARS-CoV-2 infection.
Moderna's COVID-19 vaccine is a messenger RNA (mRNA) based vaccine for COVID-19. The host cell receives instructions from the mRNA to produce the unique S-antigen protein SARS-CoV-2, so that the body can generate an immune response and store that information in memory immune cells. Efficacy according to clinical trials in participants who received the full dose of this vaccine (two doses) and had an initial SARS-CoV-2 negative status was approximately 94% with a median follow-up period of nine weeks. All data reviewed support the conclusion that the known and potential benefits of the mRNA-1273 vaccine outweigh the known and potential risks.
The SARS-CoV-2 Vaccine (Vero Cell) is an inactivated vaccine against COVID-19 that stimulates the immune system without the risk of causing disease. Once this inactivated vaccine comes into contact with the immune system, antibody production is stimulated, so the body is ready to respond to infection with live SARS-CoV-2. This vaccine contains an adjuvant (aluminum hydroxide), to strengthen the immune system response. A large phase 3 clinical trial demonstrated that two doses at 21-day intervals had 79% efficacy against symptomatic SARS-CoV-2 infection 14 days or more after the second dose. These clinical trials are neither designed nor robust enough to demonstrate efficacy against severe disease.
COMIRNATY® is a messenger RNA (mRNA) based vaccine for COVID-19. The mRNA instructs the cell to produce an S-antigen protein (part of the spike protein) unique to SARS-CoV-2 to stimulate an immune response. In clinical trials, efficacy in participants with or without evidence of previous SARS-CoV-2 infection and who received the full dose of this vaccine (two doses) was estimated at 95% with a median follow-up period of two months.

Question and Answer

Masyarakat umum berusia lebih dari 18 tahun dapat mengecek tiket dan jadwal mulai vaksinasi di website dan aplikasi PeduliLindungi. Tiket tersebut dapat digunakan di fasilitas kesehatan atau tempat vaksinasi terdekat pada waktu mulai vaksinasi ketiga yang sudah ditentukan (minimal 3 bulan setelah vaksinasi dosis kedua).

Melalui website, masyarakat bisa mengunjungi pedulilindungi.id dan mengecek status dan tiket vaksinasi dengan memasukkan “Nama Lengkap” dan “NIK”, lalu klik periksa. Jika melalui aplikasi PeduliLindungi, masyarakat bisa mengikuti langkah-langkah berikut:

  • Buka aplikasi PeduliLindungi
  • Masuk dengan akun yang terdaftar
  • Klik menu “Profil” dan pilih “Status Vaksinasi & Hasil Tes Covid-19”
  • Status dan jadwal vaksinasi booster akan muncul di akun 
  • Untuk cek tiket, masuk ke menu “Riwayat dan Tiket Vaksin”

sumber: Kemenkes

Semua Warga Negara Indonesia usia 18 Tahun ke atas berhak mendapatkan vaksin booster.

sumber: Kemenkes

Kombinasi vaksin booster yang saat ini diberikan berdasarkan pertimbangan para peneliti dalam dan luar negeri serta sudah dikonfirmasi oleh Badan POM dan ITAGI, meliputi:

  1. Untuk sasaran dengan vaksin primer Sinovac dapat diberikan separuh dosis Astra Zeneca (0,25 ml), atau separuh dosis Pfizer (0,15 ml), atau dosis penuh Moderna (0,5 ml), atau dosis penuh Sinopharm (0,5 ml dosis), atau dosis penuh Sinovac (0,5 ml), atau dosis penuh Zifivax (0,5 ml)
  2. Untuk sasaran dengan vaksin primer Astra Zeneca dapat diberikan dosis penuh Astra Zeneca (0,5 ml), atau separuh dosis Pfizer (0,15 ml), atau separuh dosis Moderna (0,25 ml)
  3. Untuk sasaran dengan vaksin primer Pfizer dapat diberikan dosis penuh Pfizer (0,3 ml), atau separuh dosis Moderna (0,25 ml), atau dosis penuh Astra Zeneca (0,5 ml)
  4. Untuk sasaran dengan vaksin primer Moderna dapat diberikan separuh dosis Moderna (0,25 ml)
  5. Untuk sasaran dengan vaksin primer Janssen (J&) dapat diberikan separuh dosis Moderna (0,25 ml)
  6. Untuk sasaran dengan vaksin primer Sinopharm dapat diberikan dosis penuh Sinopharm (0,5 ml) atau dosis penuh Zifivax (0,5 ml)

Bila ada regimen dosis lanjutan yang baru akan disampaikan kemudian.

*Perkembangan kebijakan 28 Mei 2022

sumber: Kemenkes

Tidak bisa. Jadwal yang tercantum pada aplikasi PeduliLindungi sudah disesuaikan dengan ketentuan pemerintah yang mengharuskan minimal 3 bulan dari dosis kedua.

sumber: Kemenkes

Masyarakat tidak dapat memilih jenis vaksinasi booster. Jenis booster telah ditentukan sesuai regimen yang ditentukan oleh Pemerintah dan dapat diakses di sini. Jenis vaksin akan ditentukan oleh petugas kesehatan berdasarkan riwayat vaksin dosis 1 dan 2 serta ketersediaan vaksin di tempat layanan.

sumber: Kemenkes

Cara Cek Sertifikat Vaksinasi Di PeduliLindungi?

Sudah divaksinasi? Sekarang ada cara mudah untuk mengecek sertifikat vaksin.

Cara cek sertifikat vaksin dengan NIK sangat mudah dan cepat lho. Status sertifikat vaksinmu dapat langsung diketahui. Berikut langkah-langkahnya:

  1. Buka situs https://pedulilindungi.id
  2. Isilah nama lengkap dan nomor induk kependudukan (NIK) yang diminta
  3. Centang kolom captcha "I'm not a robot"
  4. Klik "Periksa" dan status vaksin COVID-19 akan muncul.

Jika kamu telah divaksin, secara otomatis sertifikat vaksin sudah akan termuat dalam sistem. Namun jika belum, kamu bisa menunggu 7-10 hari setelah vaksin.

Bila sertifikat tidak tersedia, hubungi CALL CENTER 119 dengan extension 9 untuk mendapatkan bantuan.

Ingat, jangan mengumbar data ataupun sertifikat vaksinasi sembarangan atau ke publik karena ada banyak data pribadi berharga di situ yang dapat disalahgunakan pihak tidak bertanggung jawab.



 

Info Penting